School of Medicine

Medicine & Life Sciences

1. Scotland 100%
2. Therapeutics 56%
3. Bronchiectasis 55%
4. Type 2 Diabetes Mellitus 54%
5. Neoplasms 53%
6. Randomized Controlled Trials 51%
7. Systematic Reviews 48%
8. Population 48%
9. Cohort Studies 47%
10. Meta-Analysis 42%
11. Primary Health Care 40%
12. Heart Failure 39%
13. Genome-Wide Association Study 37%
14. Spermatozoa 37%
15. Genes 37%
16. Pharmaceutical Preparations 36%
17. Mortality 35%
18. Health 33%
19. Guidelines 32%
20. Asthma 32%
21. Delivery of Health Care 31%
22. Biomarkers 31%
23. Pandemics 30%
24. Glutathione Transferase 30%
25. Proteins 29%
26. Child 29%
27. Breast Neoplasms 28%
28. Stroke 27%
29. Skin 27%
30. Colorectal Neoplasms 27%
31. Liver 26%
32. Mutation 26%
33. Education 25%
34. Phenotype 25%
35. Chronic Obstructive Pulmonary Disease 25%
36. Confidence Intervals 24%
37. Observational Studies 24%
38. Safety 23%
39. Learning 23%
40. Placebos 23%
41. Glucose 22%
42. Insulin 22%
43. Hypoglycemia 22%
44. Students 22%
45. Kidney 22%
46. Coronavirus 22%
47. Quality of Life 22%
48. Incidence 21%
49. GABA-A Receptors 21%
50. Metformin 21%
51. Lung 21%
52. Pain 21%
53. Infections 20%
54. Databases 20%
55. Cardiovascular Diseases 20%
56. Type 1 Diabetes Mellitus 20%
57. Blood Pressure 20%
58. Medical Students 20%
59. Phosphotransferases 20%
60. Genome 20%
61. Equipment and Supplies 19%
62. Attention Deficit Disorder with Hyperactivity 19%
63. Exercise 19%
64. Costs and Cost Analysis 19%
65. Clinical Trials 19%
66. Enzymes 19%
67. Odds Ratio 18%
68. Datasets 18%
69. Phosphorylation 18%
70. Ciliary Motility Disorders 18%
71. Chronic Pain 18%
72. SARS Virus 17%
73. Hepatitis C 17%
74. Prospective Studies 17%
75. General Practice 17%
76. Breast 17%
77. Brain 17%
78. Elasticity Imaging Techniques 16%
79. Referral and Consultation 16%
80. Inflammation 16%
81. Early Detection of Cancer 16%
82. Blood Vessels 16%
83. Obesity 16%
84. Hospitalization 16%
85. Anti-Bacterial Agents 15%
86. Medical Schools 15%
87. Wounds and Injuries 15%
88. Interviews 15%
89. Depression 15%
90. Cost-Benefit Analysis 15%
91. Morbidity 15%
92. Magnetic Resonance Imaging 15%
93. Medical Education 15%
94. Pharmacology 15%
95. Survival 15%
96. Health Care Outcome Assessment 15%
97. Retrospective Studies 14%
98. In Vitro Techniques 14%
99. Hemoglobins 14%
100. Adrenal Cortex Hormones 14%